Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcineurin is a calcium- and calmodulin-dependent serine/threonine protein phosphatase that serves as a critical junction in T-cell activation pathways (UniProt P16298). It consists of a catalytic subunit, Calcineurin A, and a regulatory subunit, Calcineurin B. The enzyme's primary biological role is the dephosphorylation of the Nuclear Factor of Activated T-cells (NFAT), a step required for NFAT's translocation into the nucleus to induce the expression of interleukin-2 (IL-2) and other pro-inflammatory cytokines (StatPearls, Calcineurin Inhibitors). In the context of pharmacology, Calcineurin A is the target of the immunosuppressant Cyclosporine A. Cyclosporine first binds to the intracellular immunophilin Cyclophilin A; this binary complex then binds to Calcineurin A, sterically blocking its active site and inhibiting its phosphatase activity (DrugBank DB00091). This inhibition effectively suppresses the immune response, making it a vital target for preventing organ transplant rejection and managing autoimmune diseases like psoriasis and rheumatoid arthritis (PubMed PMID: 1703530). However, therapeutic use is limited by significant safety concerns, most notably dose-dependent nephrotoxicity and neurotoxicity.
Inhibition of Calcineurin phosphatase activity through the formation of a drug-immunophilin (Cyclosporine-Cyclophilin A) complex that sterically hinders the enzyme's active site, preventing the dephosphorylation of NFAT.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 3 catalytic subunit alpha (Calcineurin A) (PPP3CA).